Semaglutide Semaglutide (Ozempic, Wegowy) is another GLP-1 receptor agonist that has a similar mechanism of action as liraglutide, and the FDA also approves it for the same indications
If OCT is combined with targeted probes or nano-contrast agents, functional imaging is expected to be realized in the future, enabling the labeling of ferroptosis and the assessment of retinal oxidative stress distribution
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-alpha 2b plus ribavirin
Immuno-electron microscopy Under ketamine/xylazine anesthesia as described above, mice (n = 3
It goes one step further as a triple-agonist, targeting GLP-1, GIP, and glucagon receptors, which may enhance fat metabolism